An Update Review of Biosimilars of Adalimumab in Psoriasis-Bioequivalence and Interchangeability

Zhou, X; Chen, Z; Bi, XL

Bi, XL (corresponding author), Naval Med Univ, Changhai Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2021; 15 (): 2987

Abstract

Biologic drugs have revolutionized the treatment of psoriasis and other rheumatological diseases. In recent years, many biosimilar agents that are hig......

Full Text Link